Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Journal of Mass Spectrometry : JMS|July 1, 2006
A new strategy utilizing electrospray ionization-quadrupole ion trap mass spectrometry for the qualitative determination of GnRH peptidesTanya R Myers, Gabor PatonayHuman Vaccines & Immunotherapeutics|September 22, 2017
Current safety issues with quadrivalent meningococcal conjugate vaccinesTanya R Myers, Michael M McNeilMedicine|March 18, 2016
Antiretroviral Therapy and Viral Suppression Among Foreign-Born HIV-Infected Persons Receiving Medical Care in the United States: A Complex Sample, Cross-Sectional SurveyTanya R Myers, Xia Lin, Jacek SkarbinskiOpen Forum Infectious Diseases|July 18, 2019
Estimation of the Incidence of Guillain-Barré Syndrome During Pregnancy in the United StatesTanya R Myers, Natalie L McCarthy, Lakshmi Panagiotakopoulos, et al.Human Vaccines & Immunotherapeutics|June 7, 2024
Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020-May 19, 2023Casey E Parker, Anne M Hause, Paige Marquez, et al.Vaccine|June 30, 2026
V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023Tanya R Myers, Lauren H Zauche, Paige L Marquez, et al.Vaccine|March 7, 2017
Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015Tanya R Myers, Michael M McNeil, Carmen S Ng, et al.MMWR. Morbidity and Mortality Weekly Report|September 30, 2021
Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021Anne M Hause, James Baggs, Julianne Gee, et al.Sexually Transmitted Diseases|April 22, 2024
JYNNEOS Vaccine Safety Surveillance During the 2022 Mpox Outbreak Using the Vaccine Adverse Event Reporting System and V-safe, United States, 2022 to 2023Jonathan Duffy, Tanya R Myers, Paige Marquez, et al.Vaccine|August 5, 2020
Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016Tanya R Myers, Michael M McNeil, Carmen S Ng, et al.Pageof 4